학술논문
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)
Document Type
Artikel
Author
Source
Frontiers in aging neuroscience. 16:1308577
Subject
Language
English
English
English
ISSN
1663-4365